| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CAO And COO | Ca And Co
1 company
Ence Chuck is a CAO And COO at RELMADA THERAPEUTICS, INC.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | RLMD Relmada Therapeutics, Inc. | CAO And COO | Buy | 136,000 | $2.20 | $299,200.00 | +50.8% | +51.4% | - | |
| May 16, 2025 | RLMD Relmada Therapeutics, Inc. | Ca And Co | Buy | 228,961 | $0.45 | $103,330.10 | +587.5% | +31.7% | - | |
| Jan 31, 2024 | RLMD Relmada Therapeutics, Inc. | Ca And Co | Buy | 38,970 | $3.87 | $150,920.13 | +108.0% | -7.4% | -91.0% |